Annual FCF
-$33.10 M
+$51.50 M+60.88%
31 December 2022
Summary:
Catalyst Biosciences annual free cash flow is currently -$33.10 million, with the most recent change of +$51.50 million (+60.88%) on 31 December 2022. During the last 3 years, it has risen by +$51.50 million (+60.88%).CBIO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$3.22 M
-$746.00 K-30.19%
30 September 2023
Summary:
Catalyst Biosciences quarterly free cash flow is currently -$3.22 million, with the most recent change of -$746.00 thousand (-30.19%) on 30 September 2023.CBIO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$13.38 M
+$4.06 M+23.28%
30 September 2023
Summary:
Catalyst Biosciences TTM free cash flow is currently -$13.38 million, with the most recent change of +$4.06 million (+23.28%) on 30 September 2023.CBIO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +60.9% | +81.8% | +84.2% |
| 5 y5 years | +24.2% | +60.2% | +69.4% |
CBIO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -124.5% | -101.9% | -108.4% |
Catalyst Biosciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$3.22 M(+30.2%) | -$13.38 M(-23.3%) |
| June 2023 | - | -$2.47 M(-60.2%) | -$17.44 M(-36.0%) |
| Mar 2023 | - | -$6.22 M(+321.4%) | -$27.26 M(-17.6%) |
| Dec 2022 | -$33.10 M(-60.9%) | -$1.48 M(-79.7%) | -$33.10 M(-32.9%) |
| Sept 2022 | - | -$7.28 M(-40.8%) | -$49.30 M(-23.1%) |
| June 2022 | - | -$12.29 M(+2.0%) | -$64.11 M(-11.3%) |
| Mar 2022 | - | -$12.05 M(-31.8%) | -$72.29 M(-14.5%) |
| Dec 2021 | -$84.59 M(+52.9%) | -$17.68 M(-20.0%) | -$84.59 M(-5.0%) |
| Sept 2021 | - | -$22.09 M(+7.9%) | -$89.07 M(+11.1%) |
| June 2021 | - | -$20.47 M(-16.0%) | -$80.18 M(+7.1%) |
| Mar 2021 | - | -$24.36 M(+9.9%) | -$74.86 M(+35.3%) |
| Dec 2020 | -$55.31 M(+26.6%) | -$22.15 M(+67.8%) | -$55.31 M(+34.1%) |
| Sept 2020 | - | -$13.20 M(-12.9%) | -$41.25 M(+11.0%) |
| June 2020 | - | -$15.15 M(+215.2%) | -$37.15 M(+10.9%) |
| Mar 2020 | - | -$4.81 M(-40.6%) | -$33.51 M(-23.3%) |
| Dec 2019 | -$43.68 M(+51.0%) | -$8.09 M(-11.1%) | -$43.68 M(-2.5%) |
| Sept 2019 | - | -$9.10 M(-21.0%) | -$44.77 M(+4.9%) |
| June 2019 | - | -$11.52 M(-23.1%) | -$42.70 M(+10.6%) |
| Mar 2019 | - | -$14.97 M(+63.0%) | -$38.60 M(+33.4%) |
| Dec 2018 | -$28.93 M(+44.9%) | -$9.19 M(+30.8%) | -$28.93 M(+10.9%) |
| Sept 2018 | - | -$7.02 M(-5.3%) | -$26.08 M(+8.7%) |
| June 2018 | - | -$7.42 M(+39.8%) | -$23.99 M(+14.4%) |
| Mar 2018 | - | -$5.30 M(-16.3%) | -$20.97 M(+5.1%) |
| Dec 2017 | -$19.96 M(+5.4%) | -$6.34 M(+28.6%) | -$19.96 M(+6.6%) |
| Sept 2017 | - | -$4.93 M(+12.0%) | -$18.73 M(-1.1%) |
| June 2017 | - | -$4.40 M(+2.5%) | -$18.93 M(+2.9%) |
| Mar 2017 | - | -$4.29 M(-15.8%) | -$18.40 M(-2.8%) |
| Dec 2016 | -$18.94 M(-2.3%) | -$5.10 M(-0.6%) | -$18.94 M(-0.7%) |
| Sept 2016 | - | -$5.13 M(+32.3%) | -$19.08 M(+4.5%) |
| June 2016 | - | -$3.88 M(-19.8%) | -$18.26 M(-7.7%) |
| Mar 2016 | - | -$4.83 M(-7.8%) | -$19.78 M(+2.0%) |
| Dec 2015 | -$19.39 M(-43.8%) | -$5.24 M(+21.7%) | -$19.39 M(+12.7%) |
| Sept 2015 | - | -$4.31 M(-20.2%) | -$17.20 M(-16.4%) |
| June 2015 | - | -$5.40 M(+21.4%) | -$20.57 M(-14.6%) |
| Mar 2015 | - | -$4.45 M(+45.7%) | -$24.09 M(-30.2%) |
| Dec 2014 | -$34.49 M | -$3.05 M(-60.2%) | -$34.49 M(-19.1%) |
| Sept 2014 | - | -$7.68 M(-13.9%) | -$42.60 M(-4.6%) |
| June 2014 | - | -$8.91 M(-40.0%) | -$44.64 M(-3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$14.85 M(+32.9%) | -$46.16 M(+13.4%) |
| Dec 2013 | -$40.70 M(-37.0%) | -$11.17 M(+15.0%) | -$40.70 M(-1.5%) |
| Sept 2013 | - | -$9.71 M(-7.0%) | -$41.33 M(-1.7%) |
| June 2013 | - | -$10.44 M(+11.2%) | -$42.03 M(-14.3%) |
| Mar 2013 | - | -$9.39 M(-20.4%) | -$49.02 M(-24.1%) |
| Dec 2012 | -$64.57 M(-24.2%) | -$11.80 M(+13.4%) | -$64.57 M(-12.2%) |
| Sept 2012 | - | -$10.40 M(-40.3%) | -$73.56 M(-9.6%) |
| June 2012 | - | -$17.43 M(-30.1%) | -$81.40 M(-6.9%) |
| Mar 2012 | - | -$24.95 M(+20.0%) | -$87.45 M(+2.7%) |
| Dec 2011 | -$85.15 M(-163.1%) | -$20.78 M(+13.9%) | -$85.15 M(+4.2%) |
| Sept 2011 | - | -$18.25 M(-22.3%) | -$81.69 M(+1.3%) |
| June 2011 | - | -$23.48 M(+3.7%) | -$80.63 M(+32.5%) |
| Mar 2011 | - | -$22.64 M(+30.7%) | -$60.84 M(-145.1%) |
| Dec 2010 | $134.99 M(-651.6%) | -$17.32 M(+0.8%) | $134.99 M(-3.9%) |
| Sept 2010 | - | -$17.18 M(+366.6%) | $140.54 M(-12.0%) |
| June 2010 | - | -$3.68 M(-102.1%) | $159.66 M(+2.0%) |
| Mar 2010 | - | $173.18 M(-1570.7%) | $156.59 M(-739.9%) |
| Dec 2009 | -$24.47 M(-19.3%) | -$11.78 M(-708.5%) | -$24.47 M(+38.8%) |
| Sept 2009 | - | $1.94 M(-128.7%) | -$17.63 M(-37.1%) |
| June 2009 | - | -$6.75 M(-14.4%) | -$28.04 M(-6.3%) |
| Mar 2009 | - | -$7.88 M(+59.6%) | -$29.95 M(-1.2%) |
| Dec 2008 | -$30.31 M(-252.4%) | -$4.94 M(-41.8%) | -$30.31 M(+6.7%) |
| Sept 2008 | - | -$8.48 M(-2.0%) | -$28.42 M(+608.7%) |
| June 2008 | - | -$8.65 M(+4.9%) | -$4.01 M(+98.9%) |
| Mar 2008 | - | -$8.25 M(+171.3%) | -$2.02 M(-110.1%) |
| Dec 2007 | $19.89 M(-281.4%) | -$3.04 M(-119.1%) | $19.89 M(+7.8%) |
| Sept 2007 | - | $15.93 M(-339.3%) | $18.46 M(-1076.1%) |
| June 2007 | - | -$6.66 M(-148.7%) | -$1.89 M(-2578.8%) |
| Mar 2007 | - | $13.66 M(-405.3%) | $76.30 K(-100.7%) |
| Dec 2006 | -$10.97 M(-58.6%) | -$4.47 M(+1.2%) | -$10.97 M(-9.3%) |
| Sept 2006 | - | -$4.42 M(-5.7%) | -$12.10 M(-16.7%) |
| June 2006 | - | -$4.69 M(-279.2%) | -$14.52 M(-13.4%) |
| Mar 2006 | - | $2.62 M(-146.7%) | -$16.76 M(-36.7%) |
| Dec 2005 | -$26.50 M(+3.1%) | -$5.60 M(-18.2%) | -$26.50 M(+26.8%) |
| Sept 2005 | - | -$6.85 M(-1.1%) | -$20.89 M(+48.8%) |
| June 2005 | - | -$6.93 M(-2.6%) | -$14.04 M(+97.4%) |
| Mar 2005 | - | -$7.12 M | -$7.12 M |
| Dec 2004 | -$25.70 M | - | - |
FAQ
- What is Catalyst Biosciences annual free cash flow?
- What is the all time high annual FCF for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Catalyst Biosciences?
- What is Catalyst Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Catalyst Biosciences?
What is Catalyst Biosciences annual free cash flow?
The current annual FCF of CBIO is -$33.10 M
What is the all time high annual FCF for Catalyst Biosciences?
Catalyst Biosciences all-time high annual free cash flow is $134.99 M
What is Catalyst Biosciences quarterly free cash flow?
The current quarterly FCF of CBIO is -$3.22 M
What is the all time high quarterly FCF for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly free cash flow is $173.18 M
What is Catalyst Biosciences TTM free cash flow?
The current TTM FCF of CBIO is -$13.38 M
What is the all time high TTM FCF for Catalyst Biosciences?
Catalyst Biosciences all-time high TTM free cash flow is $159.66 M